{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T21:08:29Z","timestamp":1789506509206,"version":"build-2803163510"},"reference-count":47,"publisher":"Bentham Science Publishers Ltd.","issue":"3","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CPB"],"published-print":{"date-parts":[[2020,3,17]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Human amniotic membrane grafting could be potentially useful in ocular surface\ncomplications due to tissue similarity and the presence of factors that reduce inflammation, vascularization,\nand scarring. However, considerations like donor-derived infectious risk and the requirement\nof an invasive surgery limit the clinical application of such treatments. Moreover, the quick depletion\nof bioactive factors after grafting reduces the efficacy of treatments. Therefore, in the current\nstudy, the possibility of nano delivery of the bioactive factors extracted from the human amniotic\nmembrane to the ocular surface was investigated.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Materials and methods:<\/jats:title>\n<jats:p>Nanoparticles were prepared using polyelectrolyte complexation from chitosan\nand dextran sulfate. The effect of polymer ratio, pH, and the amount of extract on particle size\nand encapsulation efficacy were studied using Box-Behnken response surface methodology.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>The optimum condition was obtained as follows: 4.9:1 ratio of dextran sulfate to chitosan, 600\n\u00b5L amniotic membrane extract, and pH of 6. The prepared nanoparticles had an average size of 213\nnm with 77% encapsulation efficacy. In the release test, after 10 days, approximately 50% of entrapped\nbioactive proteins were released from the nanocarriers in a controlled manner. Biological activity assessment\non endothelial cells revealed amniotic membrane extract loaded nanoparticles had a longer\nand significant increase in anti-angiogenic effect when compared to the control.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Our data elucidate the ability of nanotechnology in ocular targeted nano delivery of bioactive\ncompounds.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1389201020666191019122130","type":"journal-article","created":{"date-parts":[[2019,10,21]],"date-time":"2019-10-21T07:26:21Z","timestamp":1571642781000},"page":"256-267","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Design of Experiment, Preparation, and in vitro Biological Assessment of Human Amniotic Membrane Extract Loaded Nanoparticles"],"prefix":"10.2174","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8924-6557","authenticated-orcid":true,"given":"Avishan","family":"Shabani","sequence":"first","affiliation":[{"name":"Nanotechnology Research Centre, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9421-8750","authenticated-orcid":true,"given":"Fatemeh","family":"Atyabi","sequence":"additional","affiliation":[{"name":"Nanotechnology Research Centre, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5897-085X","authenticated-orcid":true,"given":"Mohammad R.","family":"Khoshayand","sequence":"additional","affiliation":[{"name":"Department of Drug and Food Control, Faculty of Pharmacy and Pharmaceutical Research Center, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1491-0470","authenticated-orcid":true,"given":"Reza","family":"Mahbod","sequence":"additional","affiliation":[{"name":"Noor Ophthalmology Research Center, Noor Eye Hospital, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0490-4184","authenticated-orcid":true,"given":"Reza A.","family":"Cohan","sequence":"additional","affiliation":[{"name":"Nanobiotechnology Department, New Technologies Research Group, Pasteur Institute of Iran, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5136-2122","authenticated-orcid":true,"given":"Iman","family":"Akbarzadeh","sequence":"additional","affiliation":[{"name":"Department of Chemical and Petrochemical Engineering, Sharif University of Technology, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3335-4847","authenticated-orcid":true,"given":"Haleh","family":"Bakhshandeh","sequence":"additional","affiliation":[{"name":"Nanobiotechnology Department, New Technologies Research Group, Pasteur Institute of Iran, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.preteyeres.2011.09.001","volume":"31","author":"Mohan R.R.","year":"2012","unstructured":"Mohan R.R.; Tovey J.C.; Sharma A.; Tandon A.; Gene therapy in the cornea: 2005-present. Prog Retin Eye Res 2012,31(1),43-64","journal-title":"Prog Retin Eye Res"},{"key":"ref=2","author":"Ghinelli E.","year":"2004","unstructured":"Ghinelli E.; Use of a human amniotic membrane composition for prophylaxis and treatment of diseases and conditions of the eye and skin. WO Patent 0,262,44A3 2004"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/S0002-9394(14)71693-9","volume":"124","author":"Tseng S.C.","year":"1997","unstructured":"Tseng S.C.; Prabhasawat P.; Lee S.H.; Amniotic membrane transplantation for conjunctival surface reconstruction. Am J Ophthalmol 1997,124(6),765-774","journal-title":"Am J Ophthalmol"},{"key":"ref=4","author":"Noolandi J.","year":"2005","unstructured":"Noolandi J.; Ta C.; Huie P.; Smith A.J.; Waymouth R.; Blumenkranz M.; Artificial cornea. U.S. Patent No. 6,976,997B2, 2005"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/S0161-6420(02)00958-2","volume":"109","author":"Crawford G.J.","year":"2002","unstructured":"Crawford G.J.; Hicks C.R.; Lou X.; Vijayasekaran S.; Tan D.; Mulholland B.; Chirila T.V.; Constable I.J.; The chirila keratoprosthesis: Phase I human clinical trial. Ophthalmology 2002,109(5),883-889","journal-title":"Ophthalmology"},{"key":"ref=6","author":"Darougar S","year":"2007","unstructured":"Darougar S; Darougar D.; Artificial cornea. U.S. Patent,0,168,025, 2007"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1136\/bjo.84.8.826","volume":"84","author":"Chen H.J.","year":"2000","unstructured":"Chen H.J.; Pires R.T.F.; Tseng S.C.G.; Amniotic membrane transplantation for severe neurotrophic corneal ulcers. Br J Ophthalmol 2000,84(8),826-833","journal-title":"Br J Ophthalmol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1023\/B:CATB.0000046067.25057.0a","volume":"5","author":"Burman S.","year":"2004","unstructured":"Burman S.; Tejwani S.; Vemuganti G.K.; Gopinathan U.; Sangwan V.S.; Ophthalmic applications of preserved human amniotic membrane: A review of current indications. Cell Tissue Bank 2004,5(3),161-175","journal-title":"Cell Tissue Bank"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.survophthal.2003.10.004","volume":"49","author":"Dua H.S.","year":"2004","unstructured":"Dua H.S.; Gomes J.A.P.; King A.J.; Maharajan V.S.; The amniotic membrane in ophthalmology. Surv Ophthalmol 2004,49(1),51-77","journal-title":"Surv Ophthalmol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.biomaterials.2009.09.034","volume":"31","author":"Riau A.K.","year":"2010","unstructured":"Riau A.K.; Beuerman R.W.; Lim L.S.; Mehta J.S.; Preservation, sterilization and de-epithelialization of human amniotic membrane for use in ocular surface reconstruction. Biomaterials 2010,31(2),216-225","journal-title":"Biomaterials"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"3311","DOI":"10.1016\/S0142-9612(01)00168-5","volume":"22","author":"Chirila T.V.","year":"2001","unstructured":"Chirila T.V.; An overview of the development of artificial corneas with porous skirts and the use of PHEMA for such an application. Biomaterials 2001,22(24),3311-3317","journal-title":"Biomaterials"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1001\/archopht.1940.00860130586006","volume":"23","author":"De Rotth A.","year":"1940","unstructured":"De Rotth A.; Plastic repair of conjunctival defects with fetal membranes. Arch Ophthalmol 1940,23(3),522-525","journal-title":"Arch Ophthalmol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/00003226-199509000-00006","volume":"14","author":"Kim J.C.","year":"1995","unstructured":"Kim J.C.; Tseng S.C.; Transplantation of preserved human amniotic membrane for surface reconstruction in severely damaged rabbit corneas. Cornea 1995,14(5),473-484","journal-title":"Cornea"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1016\/S0161-6420(01)00694-7","volume":"108","author":"Koizumi N.","year":"2001","unstructured":"Koizumi N.; Inatomi T.; Suzuki T.; Sotozono C.; Kinoshita S.; Cultivated corneal epithelial stem cell transplantation in ocular surface disorders. Ophthalmology 2001,108(9),1569-1574","journal-title":"Ophthalmology"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.mehy.2007.08.008","volume":"70","author":"Seo J.H.","year":"2008","unstructured":"Seo J.H.; Kim Y.H.; Kim J.S.; Properties of the amniotic membrane may be applicable in cancer therapy. Med Hypotheses 2008,70(4),812-814","journal-title":"Med Hypotheses"},{"key":"ref=16","first-page":"2230","volume":"15","author":"Choi J.A.","year":"2009","unstructured":"Choi J.A.; Jin H.J.; Jung S.; Yang E.; Choi J.S.; Chung S.H.; Joo C.K.; Effects of amniotic membrane suspension in human corneal wound healing in vitro. Mol Vis 2009,15,2230-2238","journal-title":"Mol Vis"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1002\/jbm.820251003","volume":"25","author":"Muralidharan S.","year":"1991","unstructured":"Muralidharan S.; Gu J.; Laub G.W.; Cichon R.; Daloisio C.; McGrath L.B.; A new biological membrane for pericardial closure. J Biomed Mater Res 1991,25(10),1201-1209","journal-title":"J Biomed Mater Res"},{"key":"ref=18","year":"2013","unstructured":"Tseng, S.P.; He, H.; Li, W. Purified amniotic membrane compositions and methods of use. U.S. Patent 8,153,162 B2 2013"},{"key":"ref=19","author":"Tseng S.P.","year":"2012","unstructured":"Tseng S.P.; He H.; Li W.; Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibition.U.S. Patent 8,182,840 B2, 2012"},{"key":"ref=20","author":"Tseng S.P.","year":"2013","unstructured":"Tseng S.P.; He H.; Li W.;  Amniotic membrane preparations and purified compositions and anti-inflammation methods. U.S. Patent8,182,841, 2013"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s10989-004-2433-4","volume":"10","author":"Chen Y.","year":"2003","unstructured":"Chen Y.; Mohanraj V.J.; Parkin J.E.; Chitosan-dextran sulfate nanoparticles for delivery of an anti-angiogenesis peptide. Int J Pept Res Ther 2003,10(5),621-629","journal-title":"Int J Pept Res Ther"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S0378-5173(03)00055-3","volume":"255","author":"Tiyaboonchai W.","year":"2003","unstructured":"Tiyaboonchai W.; Woiszwillo J.; Sims R.C.; Middaugh C.R.; Insulin containing polyethylenimine-dextran sulfate nanoparticles. Int J Pharm 2003,255(1-2),139-151","journal-title":"Int J Pharm"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S0378-5173(01)00614-7","volume":"218","author":"Zhang Q.","year":"2001","unstructured":"Zhang Q.; Shen Z.; Nagai T.; Prolonged hypoglycemic effect of insulin-loaded polybutylcyanoacrylate nanoparticles after pulmonary administration to normal rats. Int J Pharm 2001,218(1-2),75-80","journal-title":"Int J Pharm"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.nano.2009.04.007","volume":"6","author":"Avadi M.R.","year":"2010","unstructured":"Avadi M.R.; Sadeghi A.M.M.; Mohammadpour N.; Abedin S.; Atyabi F.; Dinarvand R.; Rafiee-Tehrani M.; Preparation and characterization of insulin nanoparticles using chitosan and Arabic gum with ionic gelation method. Nanomedicine (Lond) 2010,6(1),58-63","journal-title":"Nanomedicine (Lond)"},{"key":"ref=25","doi-asserted-by":"crossref","first-page":"10950","DOI":"10.1021\/la7008545","volume":"23","author":"Drogoz A.","year":"2007","unstructured":"Drogoz A.; David L.; Rochas C.; Domard A.; Delair T.; Polyelectrolyte complexes from polysaccharides: Formation and stoichiometry monitoring. Langmuir 2007,23(22),10950-10958","journal-title":"Langmuir"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S0928-0987(03)00102-7","volume":"19","author":"Tiyaboonchai W.","year":"2003","unstructured":"Tiyaboonchai W.; Woiszwillo J.; Middaugh C.R.; Formulation and characterization of DNA-polyethylenimine-dextran sulfate nanoparticles. Eur J Pharm Sci 2003,19(4),191-202","journal-title":"Eur J Pharm Sci"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1080\/00914037.2015.1038816","volume":"64","author":"Siyawamwaya M.","year":"2015","unstructured":"Siyawamwaya M.; Choonara Y.E.; Bijukumar D.; Kumar P.; Du Toit L.C.; Pillay V.; A review: Overview of novel polyelectrolyte complexes as prospective drug bioavailability enhancers. Int J Polym Mats Polym Biomat 2015,64(18),955-968","journal-title":"Int J Polym Mats Polym Biomat"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ejpb.2010.12.001","volume":"78","author":"Delair T.","year":"2011","unstructured":"Delair T.; Colloidal polyelectrolyte complexes of chitosan and dextran sulfate towards versatile nanocarriers of bioactive molecules. Eur J Pharm Biopharm 2011,78(1),10-18","journal-title":"Eur J Pharm Biopharm"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2174\/2405465803666180409130241","volume":"3","author":"Raj S.","year":"2018","unstructured":"Raj S.; Kumar Sharma P.; Malviya R.; Pharmaceutical and tissue engineering applications of polyelectrolyte complexes. Curr Smart Mater 2018,3(1),21-31","journal-title":"Curr Smart Mater"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"10950","DOI":"10.1021\/la7008545","volume":"23","author":"Drogoz A.","year":"2007","unstructured":"Drogoz A.; David L.; Rochas C.; Domard A.; Delair T.; Polyelectrolyte complexes from polysaccharides: Formation and stoichiometry monitoring. Langmuir 2007,23(22),10950-10958","journal-title":"Langmuir"},{"key":"ref=31","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/978-981-10-3328-5_2","author":"Buriuli M.","year":"2017","unstructured":"Buriuli M.; Verma D.; Polyelectrolyte Complexes (PECs) for Biomedical Applications. Advances in Biomaterials for Biomedical Applications; Springer,2017,45-93","journal-title":"Advances in Biomaterials for Biomedical Applications;"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.nano.2008.09.006","volume":"5","author":"Moghaddam F.A.","year":"2009","unstructured":"Moghaddam F.A.; Atyabi F.; Dinarvand R.; Preparation and in vitro evaluation of mucoadhesion and permeation enhancement of thiolated chitosan-pHEMA core-shell nanoparticles. Nanomedicine, (Lond), 2009,5(2),208-215","journal-title":"Nanomedicine, (Lond),"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.nano.2010.01.011","volume":"6","author":"Akhlaghi S.P.","year":"2010","unstructured":"Akhlaghi S.P.; Saremi S.; Ostad S.N.; Dinarvand R.; Atyabi F.; Discriminated effects of thiolated chitosan-coated pMMA paclitaxel-loaded nanoparticles on different normal and cancer cell lines. Nanomedicine, (Lond), 2010,6(5),689-697","journal-title":"Nanomedicine, (Lond),"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/BF02442596","volume":"10","author":"Chen Y.","year":"2003","unstructured":"Chen Y.; Mohanraj V.J.; Parkin J.E.; Chitosan-dextran sulfate nanoparticles for delivery of an anti-angiogenesis peptide. Lett Pept Sci 2003,10(5-6),621-629","journal-title":"Lett Pept Sci"},{"key":"ref=35","doi-asserted-by":"publisher","DOI":"10.1208\/pt0804098","volume":"8","author":"Chen Y.","year":"2007","unstructured":"Chen Y.; Mohanraj V.J.; Wang F.; Benson H.A.; Designing chitosan-dextran sulfate nanoparticles using charge ratios. AAPS PharmSciTech 2007,8(4)","journal-title":"AAPS PharmSciTech"},{"key":"ref=36","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1089\/jop.2012.0193","volume":"29","author":"Chaiyasan W.","year":"2013","unstructured":"Chaiyasan W.; Srinivas S.P.; Tiyaboonchai W.; Mucoadhesive chitosan-dextran sulfate nanoparticles for sustained drug delivery to the ocular surface. J Ocul Pharmacol Ther 2013,29(2),200-207","journal-title":"J Ocul Pharmacol Ther"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.ijpharm.2006.08.013","volume":"329","author":"Tiyaboonchai W.","year":"2007","unstructured":"Tiyaboonchai W.; Limpeanchob N.; Formulation and characterization of amphotericin B-chitosan-dextran sulfate nanoparticles. Int J Pharm 2007,329(1-2),142-149","journal-title":"Int J Pharm"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1002\/jps.21412","volume":"98","author":"Huang M.","year":"2009","unstructured":"Huang M.; Berkland C.; Controlled release of repifermin from polyelectrolyte complexes stimulates endothelial cell proliferation. J Pharm Sci 2009,98(1),268-280","journal-title":"J Pharm Sci"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1021\/bm061211k","volume":"8","author":"Huang M.","year":"2007","unstructured":"Huang M.; Vitharana S.N.; Peek L.J.; Coop T.; Berkland C.; Polyelectrolyte complexes stabilize and controllably release vascular endothelial growth factor. Biomacromolecules 2007,8(5),1607-1614","journal-title":"Biomacromolecules"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0141-8130(00)00118-5","volume":"27","author":"Sabnis S.","year":"2000","unstructured":"Sabnis S.; Block L.H.; Chitosan as an enabling excipient for drug delivery systems. I. Molecular modifications. Int J Biol Macromol 2000,27(3),181-186","journal-title":"Int J Biol Macromol"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ijpharm.2004.05.019","volume":"281","author":"Mao S.","year":"2004","unstructured":"Mao S.; Shuai X.; Unger F.; Simon M.; Bi D.; Kissel T.; The depolymerization of chitosan: Effects on physicochemical and biological properties. Int J Pharm 2004,281(1-2),45-54","journal-title":"Int J Pharm"},{"key":"ref=42","doi-asserted-by":"crossref","first-page":"282","DOI":"10.2485\/jhtb.25.282","volume":"25","author":"Lee H.N.","year":"2016","unstructured":"Lee H.N.; Bernardo R.; Han G.Y.; Kim G.Y.; Kim J.S.; Jung W.Y.; Kim K.N.; Kim J.C.; Kim C.W.; Human amniotic membrane extracts have anti-inflammatory effects on damaged human corneal epithelial cells in vitro. J Hard Tissue Biol [https:\/\/www.jstage.jst.go.jp\/article\/jhtb\/25\/3\/25_282\/_article2016,25(3),282-287","journal-title":"J Hard Tissue Biol"},{"key":"ref=43","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.neuro.2019.10.001","volume":"76","author":"Zamproni L.N.","year":"2020","unstructured":"Zamproni L.N.; Teixeira D.; Alliegro A.A.; Maug\u00e9ri I.L.; des Rieux A.; Porcionatto M.A.; Decreased viability and neurite length in neural cells treated with chitosan-dextran sulfate nanocomplexes. Neurotoxicology [https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161813X193010812020,76,33-43","journal-title":"Neurotoxicology"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1023\/A:1026498209874","volume":"17","author":"van de Weert M.","year":"2000","unstructured":"van de Weert M.; Hennink W.E.; Jiskoot W.; Protein instability in poly(lactic-co-glycolic acid) microparticles. Pharm Res 2000,17(10),1159-1167","journal-title":"Pharm Res"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s10989-005-9010-3","volume":"12","author":"Sarmento B.","year":"2006","unstructured":"Sarmento B.; Martins S.; Ribeiro A.; Veiga F.; Neufeld R.; Ferreira D.; Development and comparison of different nanoparticulate polyelectrolyte complexes as insulin carriers. Int J Pept Res Ther 2006,12(2),131-138","journal-title":"Int J Pept Res Ther"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"S36","DOI":"10.1097\/01.ico.0000247211.78391.af","volume":"25","author":"Jiang A.","year":"2006","unstructured":"Jiang A.; Li C.; Gao Y.; Zhang M.; Hu J.; Kuang W.; Hao S.; Yang W.; Xu C.; Gao G.; Wang Z.; Liu Z.; \n                        In vivo and in vitro inhibitory effect of amniotic extraction on neovascularization. Cornea 2006,25(10)(Suppl. 1),S36-S40","journal-title":"Cornea"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"9823","DOI":"10.1021\/la201898v","volume":"27","author":"Bharti B.","year":"2011","unstructured":"Bharti B.; Meissner J.; Findenegg G.H.; Aggregation of silica nanoparticles directed by adsorption of lysozyme. Langmuir 2011,27(16),9823-9833","journal-title":"Langmuir"}],"container-title":["Current Pharmaceutical Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/175895","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T06:14:58Z","timestamp":1586326498000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/175895\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,17]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3,17]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1389201020666191019122130","relation":{},"ISSN":["1389-2010"],"issn-type":[{"value":"1389-2010","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3,17]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2019-06-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-09-15","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-10-02","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-03-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}